Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

NCT02284269 · clinicaltrials.gov ↗

UNKNOWN

Status

18000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: SGLT2 Inhibitors

Sponsor

Pharmaceuticals and Medical Devices Agency, Japan